Our Pricing

Wegovy Pricing UK - All Doses Available Now

Published on: June 03, 2026

If you're comparing wegovy pricing uk online pharmacy options, Cured Pharmacy offers transparent upfront costs from £79.00, with all doses available and a free clinical consultation completed in under 3 minutes. Our UK-registered prescribers assess your suitability for this MHRA-licensed semaglutide treatment, with discreet next-day delivery across the UK.

Understanding Wegovy Pricing UK: What You're Actually Paying For

Wegovy pricing in the UK reflects the cost of the semaglutide injection pen, clinical consultation, and dispensing by a UK-registered pharmacy. At Cured Pharmacy, our pricing from £79.00 includes your online assessment by a qualified UK prescriber, the genuine MHRA-licensed medication, and discreet packaging delivered to your door [1].

Unlike some services that add hidden consultation fees or subscription charges, we display the full cost before you start your assessment. Your final price depends on the dose prescribed by your clinician, which is determined by your medical history, current weight, and treatment progress. All Wegovy pens contain four pre-filled injections for one month of weekly treatment [2].

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone your body produces after eating [1]. By activating GLP-1 receptors in the brain, pancreas, and digestive system, semaglutide reduces appetite, slows gastric emptying, and improves blood sugar regulation—all mechanisms that support weight loss when combined with lifestyle changes.

In the landmark STEP 1 clinical trial, participants using semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2]. These results led to Wegovy's MHRA approval in 2023 for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [3].

The Five Wegovy Doses Explained

Wegovy treatment follows a gradual dose escalation schedule to minimise gastrointestinal side effects. You'll start with 0.25mg weekly for four weeks, then increase to 0.5mg, 1mg, 1.7mg, and finally the maintenance dose of 2.4mg weekly [1]. Each pen contains four identical doses for one month of treatment. Your prescriber will determine when you're ready to progress to the next dose based on your tolerance and response.

Wegovy vs Mounjaro: Comparing Semaglutide and Tirzepatide

Wegovy and Mounjaro represent two different generations of injectable weight loss treatments. Wegovy contains semaglutide, a GLP-1 receptor agonist, while Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK [4]. Both are once-weekly injections requiring prescription approval from a UK clinician.

Head-to-head trials suggest tirzepatide produces slightly greater weight loss on average—up to 22.5% body weight reduction in the SURPASS-3 trial compared to semaglutide's 14.9% in STEP 1 [2][5]. However, individual responses vary considerably, and your prescriber will recommend the most appropriate treatment based on your medical history, current medications, and personal preferences. Both treatments require ongoing lifestyle modifications including reduced calorie intake and increased physical activity.

Which Treatment Is Right for You?

During your free online consultation at Cured Pharmacy, our UK prescribers assess factors including your BMI, weight loss goals, previous treatment history, and any contraindications. Some patients prefer starting with Wegovy due to the extensive clinical trial data and established safety profile, while others opt for Mounjaro's dual-action mechanism. Both medications are subject to the same prescribing criteria and require regular monitoring by a healthcare professional.

Wegovy Pricing UK: Dose-by-Dose Breakdown

Wegovy pricing varies by dose strength, with starter doses typically costing less than the maintenance 2.4mg dose. At Cured Pharmacy, we maintain competitive pricing across all five dose strengths, with transparent costs displayed before you begin your clinical assessment. Most patients progress through the full dose escalation over 16-20 weeks before reaching the maintenance dose.

Your first month on Wegovy 0.25mg starts from £79.00, and you'll continue at each dose level for at least four weeks before escalating. This gradual approach, recommended by the manufacturer and MHRA guidelines, significantly reduces the risk of nausea, vomiting, and other gastrointestinal side effects that can occur when starting GLP-1 treatments [1][3]. Our superintendent pharmacist Tarun Kumar and clinical team monitor your progress and can adjust the escalation schedule if needed.

What's Included in Your Wegovy Prescription from Cured Pharmacy

When you order Wegovy through Cured Pharmacy, your price includes a comprehensive service beyond just the medication. You'll complete a free online consultation reviewed by a UK-registered prescriber, receive genuine MHRA-licensed Wegovy pens dispensed by our GPhC-registered pharmacy (9012511), and benefit from discreet packaging with next-day delivery across the UK.

We also provide ongoing clinical support throughout your treatment. If you experience side effects or have questions about dose escalation, our team is available by phone on (+44) 116 4646009 during business hours. Unlike subscription models that lock you into recurring charges, you control when to reorder based on your treatment progress and prescriber recommendations. Every Wegovy pen is stored and handled according to strict temperature-controlled protocols to maintain medication integrity.

No Hidden Fees or Subscription Traps

Some online services advertise low headline prices but add consultation fees, delivery charges, or mandatory subscription renewals. At Cured Pharmacy, the price you see includes everything except your ongoing monthly medication cost. There are no membership fees, no automatic renewals, and no pressure to continue treatment beyond what your prescriber recommends. You order when you're ready for your next dose, giving you complete control over your weight loss journey.

Starting Your Wegovy Treatment: The Clinical Assessment Process

All Wegovy prescriptions in the UK legally require approval from a registered prescriber following a clinical assessment. At Cured Pharmacy, this process takes under 3 minutes and covers your medical history, current medications, weight loss goals, and any contraindications. Our prescribers assess whether Wegovy is suitable based on NICE and MHRA guidelines, which specify minimum BMI thresholds and exclude certain medical conditions [3].

If approved, your prescription is sent electronically to our dispensing pharmacy, and your Wegovy pen is dispatched the same day for next-day delivery. If our prescriber determines Wegovy isn't appropriate for you—perhaps due to a contraindication or insufficient BMI—they'll explain why and may suggest alternative treatments. This safeguarding process protects patient safety and ensures you receive the most appropriate care. You can start your free assessment now by clicking the 'Start Assessment' button on this page.

What Happens After Approval

Once your prescription is approved, you'll receive confirmation via email along with injection technique guidance and lifestyle modification resources. Your Wegovy pen arrives in temperature-controlled packaging to maintain the cold chain required for semaglutide stability. Each pen should be stored in the refrigerator between 2°C and 8°C until use, though it can remain at room temperature for up to 28 days if needed [1]. Our pharmacist team provides full instructions on injection technique, disposal of used pens, and what to do if you miss a dose.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Public Assessment Report. GOV.UK. https://www.gov.uk/government/publications/mounjaro-tirzepatide [accessed 13 August 2026]
5. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is indicated for chronic weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities, alongside a reduced-calorie diet and increased physical activity.